Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Falkson

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reports|July 1, 1985
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancerG Falkson, R S Gelman, D C Tormey, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 17, 1976
Adriamycin in the treatment of cancerJ J van Dyk, A M van der Merwe, H C Falkson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 1, 1982
Adjuvant chemotherapy for operable breast cancer in premenopausal womenH C Falkson, G Falkson, M A Portugal, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 11, 1983
Adjuvant chemotherapy for operable breast cancer in postmenopausal womenH C Falkson, G Falkson, H S Schoeman, et al.
Oncology|January 1, 1990
Plasma melatonin in patients with breast cancerG Falkson, H C Falkson, M E Steyn, et al.
American Journal of Clinical Oncology|February 1, 1982
Dibromodulcitol and adriamycin +/- tamoxifen in advanced breast cancerD C Tormey, G Falkson, J Crowley, et al.
Cancer|September 1, 1978
Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapyH C Falkson, J J Van Der Watt, M A Portugal, et al.
Cancer|May 1, 1982
Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapyH C Falkson, G Falkson, M A Portugal, et al.
Cancer Treatment Reports|August 1, 1979
Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapyH C Falkson, J J van der Watt, M A Portugal, et al.
Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reports|July 1, 1985
Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancerG Falkson, R S Gelman, D C Tormey, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 17, 1976
Adriamycin in the treatment of cancerJ J van Dyk, A M van der Merwe, H C Falkson, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 1, 1982
Adjuvant chemotherapy for operable breast cancer in premenopausal womenH C Falkson, G Falkson, M A Portugal, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 11, 1983
Adjuvant chemotherapy for operable breast cancer in postmenopausal womenH C Falkson, G Falkson, H S Schoeman, et al.
Oncology|January 1, 1990
Plasma melatonin in patients with breast cancerG Falkson, H C Falkson, M E Steyn, et al.
American Journal of Clinical Oncology|February 1, 1982
Dibromodulcitol and adriamycin +/- tamoxifen in advanced breast cancerD C Tormey, G Falkson, J Crowley, et al.
Cancer|September 1, 1978
Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapyH C Falkson, J J Van Der Watt, M A Portugal, et al.
Cancer|May 1, 1982
Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapyH C Falkson, G Falkson, M A Portugal, et al.
Cancer Treatment Reports|August 1, 1979
Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapyH C Falkson, J J van der Watt, M A Portugal, et al.
Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.
Pageof 6